Last update 08 Nov 2025

SNC-115

Overview

Basic Info

Drug Type
CAR-T
Synonyms
SNC 115, SNC115
Target
DLL3
Action
modulators
Mechanism
DLL3 modulators(Delta-like protein 3 modulators)
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
Large cell neuroendocrine carcinoma of lungSmall Cell Lung CancerRecurrent Lung Small Cell Carcinoma+ [2]
Inactive Indication-
Originator Organization
Shanghai Simnova Biotechnology Co.,Ltd.
Active Organization
Shanghai Simnova Biotechnology Co.,Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SNC-115
NCT06384482
/ RecruitingPhase 1
To Evaluate the Safety and Pharmacokinetic of SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Crcinoma: an Open-label, Single-arm, Dose Escalation Exploratory Study
100 Clinical Results associated with SNC-115
Login to view more data
100 Translational Medicine associated with SNC-115
Login to view more data
100 Patents (Medical) associated with SNC-115
Login to view more data
100 Deals associated with SNC-115
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Large cell neuroendocrine carcinoma of lungPhase 1
China
Shanghai Simnova Biotechnology Co.,Ltd.
30 Apr 2024
Small Cell Lung CancerPhase 1
China
Shanghai Simnova Biotechnology Co.,Ltd.
30 Apr 2024
Recurrent Lung Small Cell CarcinomaIND Approval
China
Shanghai Simnova Biotechnology Co.,Ltd.
30 Oct 2025
Refractory Small Cell Lung CarcinomaIND Approval
China
Shanghai Simnova Biotechnology Co.,Ltd.
30 Oct 2025
Solid tumorDiscovery-
Shanghai Simnova Biotechnology Co.,Ltd.
25 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free